A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid Leukemia
Clinical trial NCT06113289 · WITHDRAWN
Trial details
- NCT number
- NCT06113289
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-08
- Primary completion
- 2025-03-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.